Sarah Cannon Moves More Than 75% of CAR-T Therapies to Outpatient Setting

Sarah Cannon, the Cancer Institute of HCA Healthcare, embarked on a transformative initiative to manage the growing demand for CAR-T therapy. Faced with the increasing volume of potentially high-acuity cases and limited inpatient capacity, the goal was to safely transition a substantial portion of CAR-T therapy to an outpatient model.

Through a partnership with Current Health, over 75% of CAR-T therapies were transitioned to outpatient care using a high-touch remote monitoring system of technology and services, leading to significant improvements in resource efficiency and patient satisfaction.

Explore our case study to gain comprehensive insights into this innovative treatment delivery program and the outcomes it has achieved.